LOGIN
Low-Molecular Weight Heparin and Aspirin Provide Similar VTE Prevention in Trauma Fracture Patients
September 2020
Low-Molecular Weight Heparin and Aspirin Provide Similar VTE Prevention in Trauma Fracture Patients
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in orthopaedic trauma patients: A patient-centered randomized controlled trial.
PloS one. 2020 Aug 3;15(8):e0235628Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Three hundred and twenty-nine patients with a traumatic extremity fracture requiring operative treatment where venous thromboembolism prophylaxis was needed were randomized to receive either low-molecular weight heparin (LMWH) or aspirin. The primary outcome of interest included the incidence of mortality, bleeding, venous thromboembolism (VTE), deep surgical site infection, and a combination of t...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Join the Conversation
Please Login or Join to leave comments.